1. RussoJJ, BohenzkyRA, ChienMC, ChenJ, YanM, et al. (1996) Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8). Proc Natl Acad Sci U S A 93: 14862–14867.
2. ChangY, CesarmanE, PessinMS, LeeF, CulpepperJ, et al. (1994) Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 266: 1865–1869.
3. CesarmanE, ChangY, MoorePS, SaidJW, KnowlesDM (1995) Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N Engl J Med 332: 1186–1191.
4. DupinN, DissTL, KellamP, TulliezM, DuMQ, et al. (2000) HHV-8 is associated with a plasmablastic variant of Castleman disease that is linked to HHV-8-positive plasmablastic lymphoma. Blood 95: 1406–1412.
5. SunR, LinSF, GradovilleL, YuanY, ZhuF, et al. (1998) A viral gene that activates lytic cycle expression of Kaposi's sarcoma-associated herpesvirus. Proc Natl Acad Sci U S A 95: 10866–10871.
6. SunR, LinSF, StaskusK, GradovilleL, GroganE, et al. (1999) Kinetics of Kaposi's sarcoma-associated herpesvirus gene expression. J Virol 73: 2232–2242.
7. LukacDM, KirshnerJR, GanemD (1999) Transcriptional activation by the product of open reading frame 50 of Kaposi's sarcoma-associated herpesvirus is required for lytic viral reactivation in B cells. J Virol 73: 9348–9361.
8. SunR, LinSF, GradovilleL, MillerG (1996) Polyadenylylated nuclear RNA encoded by Kaposi sarcoma-associated herpesvirus. Proc Natl Acad Sci U S A 93: 11883–11888.
9. CaiX, LuS, ZhangZ, GonzalezCM, DamaniaB, et al. (2005) Kaposi's sarcoma-associated herpesvirus expresses an array of viral microRNAs in latently infected cells. Proc Natl Acad Sci U S A 102: 5570–5575.
10. XuY, GanemD (2010) Making sense of antisense: seemingly noncoding RNAs antisense to the master regulator of Kaposi's sarcoma-associated herpesvirus lytic replication do not regulate that transcript but serve as mRNAs encoding small peptides. J Virol 84: 5465–5475.
11. ColganDF, ManleyJL (1997) Mechanism and regulation of mRNA polyadenylation. Genes Dev 11: 2755–2766.
12. LewisJD, GundersonSI, MattajIW (1995) The influence of 5′ and 3′ end structures on pre-mRNA metabolism. J Cell Sci Suppl 19: 13–19.
13. WickensM, AndersonP, JacksonRJ (1997) Life and death in the cytoplasm: messages from the 3′ end. Curr Opin Genet Dev 7: 220–232.
14. ShiY, DiG, TaylorD, SarkeshikA, RiceWJ, et al. (2009) Molecular architecture of the human pre-mRNA 3′ processing complex. Mol Cell 33: 365–376.
15. SalisburyJ, HutchisonKW, GraberJH (2006) A multispecies comparison of the metazoan 3′-processing downstream elements and the CstF-64 RNA recognition motif. BMC Genomics 7: 55.
16. HuJ, LutzCS, WiluszJ, TianB (2005) Bioinformatic identification of candidate cis-regulatory elements involved in human mRNA polyadenylation. RNA 11: 1485–1493.
17. BaggaPS, FordLP, ChenF, WiluszJ (1995) The G-rich auxiliary downstream element has distinct sequence and position requirements and mediates efficient 3′ end pre-mRNA processing through a trans-acting factor. Nucleic Acids Res 23: 1625–1631.
18. ChenF, WiluszJ (1998) Auxiliary downstream elements are required for efficient polyadenylation of mammalian pre-mRNAs. Nucleic Acids Res 26: 2891–2898.
19. MillevoiS, VagnerS (2010) Molecular mechanisms of eukaryotic pre-mRNA 3′ end processing regulation. Nucleic Acids Res 38: 2757–2774.
20. TianB, HuJ, ZhangH, LutzCS (2005) A large-scale analysis of mRNA polyadenylation of human and mouse genes. Nucleic Acids Res 33: 201–212.
21. MangoneM, ManoharanAP, Thierry-MiegD, Thierry-MiegJ, HanT, et al. (2010) The landscape of C. elegans 3′UTRs. Science 329: 432–435.
22. NagalakshmiU, WangZ, WaernK, ShouC, RahaD, et al. (2008) The transcriptional landscape of the yeast genome defined by RNA sequencing. Science 320: 1344–1349.
23. DiG, NishidaK, ManleyJL (2011) Mechanisms and consequences of alternative polyadenylation. Mol Cell 43: 853–866.
24. NiT, YangY, HafezD, YangW, KiesewetterK, et al. (2013) Distinct polyadenylation landscapes of diverse human tissues revealed by a modified PA-seq strategy. BMC Genomics 14: 615.
25. HafezD, NiT, MukherjeeS, ZhuJ, OhlerU (2013) Genome-wide identification and predictive modeling of tissue-specific alternative polyadenylation. Bioinformatics 29: i108–i116.
26. BoyleAP, GuinneyJ, CrawfordGE, FureyTS (2008) F-Seq: a feature density estimator for high-throughput sequence tags. Bioinformatics 24: 2537–2538.
27. ZhuFX, CusanoT, YuanY (1999) Identification of the immediate-early transcripts of Kaposi's sarcoma-associated herpesvirus. J Virol 73: 5556–5567.
28. TangS, ZhengZM (2002) Kaposi's sarcoma-associated herpesvirus K8 exon 3 contains three 5′-splice sites and harbors a K8.1 transcription start site. J Biol Chem 277: 14547–14556.
29. ChandrianiS, XuY, GanemD (2010) The lytic transcriptome of Kaposi's sarcoma-associated herpesvirus reveals extensive transcription of noncoding regions, including regions antisense to important genes. J Virol 84: 7934–7942.
30. PauwsE, van KampenAH, van de GraafSA, de VijlderJJ, Ris-StalpersC (2001) Heterogeneity in polyadenylation cleavage sites in mammalian mRNA sequences: implications for SAGE analysis. Nucleic Acids Res 29: 1690–1694.
31. DresangLR, TeutonJR, FengH, JacobsJM, CampDG, et al. (2011) Coupled transcriptome and proteome analysis of human lymphotropic tumor viruses: insights on the detection and discovery of viral genes. BMC Genomics 12: 625.
32. WangY, LiH, ChanMY, ZhuFX, LukacDM, et al. (2004) Kaposi's sarcoma-associated herpesvirus ori-Lyt-dependent DNA replication: cis-acting requirements for replication and ori-Lyt-associated RNA transcription. J Virol 78: 8615–8629.
33. WangY, TangQ, MaulGG, YuanY (2006) Kaposi's sarcoma-associated herpesvirus ori-Lyt-dependent DNA replication: dual role of replication and transcription activator. J Virol 80: 12171–12186.
34. TaylorJL, BennettHN, SnyderBA, MoorePS, ChangY (2005) Transcriptional analysis of latent and inducible Kaposi's sarcoma-associated herpesvirus transcripts in the K4 to K7 region. J Virol 79: 15099–15106.
35. MassimelliMJ, MajerciakV, KruhlakM, ZhengZM (2013) Interplay between polyadenylate-binding protein 1 and Kaposi's sarcoma-associated herpesvirus ORF57 in accumulation of polyadenylated nuclear RNA, a viral long noncoding RNA. J Virol 87: 243–256.
36. AokiY, YarchoanR, BraunJ, IwamotoA, TosatoG (2000) Viral and cellular cytokines in AIDS-related malignant lymphomatous effusions. Blood 96: 1599–1601.
37. KangJG, PripuzovaN, MajerciakV, KruhlakM, LeSY, et al. (2011) Kaposi's Sarcoma-Associated Herpesvirus ORF57 Promotes Escape of Viral and Human Interleukin-6 from MicroRNA-Mediated Suppression. J Virol 85: 2620–2630.
38. WangSS, ChangPJ, ChenLW, ChenLY, HungCH, et al. (2012) Positive and negative regulation in the promoter of the ORF46 gene of Kaposi's sarcoma-associated herpesvirus. Virus Res 165: 157–169.
39. MajerciakV, YamanegiK, ZhengZM (2006) Gene structure and expression of Kaposi's sarcoma-associated herpesvirus ORF56, ORF57, ORF58, and ORF59. J Virol 80: 11968–11981.
40. LiH, KomatsuT, DezubeBJ, KayeKM (2002) The Kaposi's sarcoma-associated herpesvirus K12 transcript from a primary effusion lymphoma contains complex repeat elements, is spliced, and initiates from a novel promoter. J Virol 76: 11880–11888.
41. SaridR, WiezorekJS, MoorePS, ChangY (1999) Characterization and cell cycle regulation of the major Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) latent genes and their promoter. J Virol 73: 1438–1446.
42. ChiouCJ, PooleLJ, KimPS, CiufoDM, CannonJS, et al. (2002) Patterns of gene expression and a transactivation function exhibited by the vGCR (ORF74) chemokine receptor protein of Kaposi's sarcoma-associated herpesvirus. J Virol 76: 3421–3439.
43. CanhamM, TalbotSJ (2004) A naturally occurring C-terminal truncated isoform of the latent nuclear antigen of Kaposi's sarcoma-associated herpesvirus does not associate with viral episomal DNA. J Gen Virol 85: 1363–1369.
44. KangJG, MajerciakV, UldrickTS, WangX, KruhlakM, et al. (2011) Kaposi's sarcoma-associated herpesviral IL-6 and human IL-6 open reading frames contain miRNA binding sites and are subject to cellular miRNA regulation. J Pathol 225: 378–389.
45. LinHR, GanemD (2011) Viral microRNA target allows insight into the role of translation in governing microRNA target accessibility. Proc Natl Acad Sci U S A 108: 5148–5153.
46. BellareP, GanemD (2009) Regulation of KSHV lytic switch protein expression by a virus-encoded microRNA: an evolutionary adaptation that fine-tunes lytic reactivation. Cell Host Microbe 6: 570–575.
47. ChandrianiS, GanemD (2010) Array-based transcript profiling and limiting-dilution reverse transcription-PCR analysis identify additional latent genes in Kaposi's sarcoma-associated herpesvirus. J Virol 84: 5565–5573.
48. PearceM, MatsumuraS, WilsonAC (2005) Transcripts encoding K12, v-FLIP, v-cyclin, and the microRNA cluster of Kaposi's sarcoma-associated herpesvirus originate from a common promoter. J Virol 79: 14457–14464.
49. MatsumuraS, FujitaY, GomezE, TaneseN, WilsonAC (2005) Activation of the Kaposi's sarcoma-associated herpesvirus major latency locus by the lytic switch protein RTA (ORF50). J Virol 79: 8493–8505.
50. ChaoLC, JamilA, KimSJ, HuangL, MartinsonHG (1999) Assembly of the cleavage and polyadenylation apparatus requires about 10 seconds in vivo and is faster for strong than for weak poly(A) sites. Mol Cell Biol 19: 5588–5600.
51. WestS, ProudfootNJ (2009) Transcriptional termination enhances protein expression in human cells. Mol Cell 33: 354–364.
52. CarswellS, AlwineJC (1989) Efficiency of utilization of the simian virus 40 late polyadenylation site: effects of upstream sequences. Mol Cell Biol 9: 4248–4258.
53. MayrC, BartelDP (2009) Widespread shortening of 3′UTRs by alternative cleavage and polyadenylation activates oncogenes in cancer cells. Cell 138: 673–684.
54. HausserJ, SyedAP, BilenB, ZavolanM (2013) Analysis of CDS-located miRNA target sites suggests that they can effectively inhibit translation. Genome Res 23: 604–615.
55. UsdinK (2008) The biological effects of simple tandem repeats: lessons from the repeat expansion diseases. Genome Res 18: 1011–1019.
56. WyersF, RougemailleM, BadisG, RousselleJC, DufourME, et al. (2005) Cryptic pol II transcripts are degraded by a nuclear quality control pathway involving a new poly(A) polymerase. Cell 121: 725–737.
57. CannonJS, CiufoD, HawkinsAL, GriffinCA, BorowitzMJ, et al. (2000) A new primary effusion lymphoma-derived cell line yields a highly infectious Kaposi's sarcoma herpesvirus-containing supernatant. J Virol 74: 10187–10193.
58. NakamuraH, LuM, GwackY, SouvlisJ, ZeichnerSL, et al. (2003) Global changes in Kaposi's sarcoma-associated virus gene expression patterns following expression of a tetracycline-inducible Rta transactivator. J Virol 77: 4205–4220.
59. LiH, DurbinR (2009) Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 25: 1754–1760.
60. LiH, HandsakerB, WysokerA, FennellT, RuanJ, et al. (2009) The Sequence Alignment/Map format and SAMtools. Bioinformatics 25: 2078–2079.
61. MortazaviA, WilliamsBA, McCueK, SchaefferL, WoldB (2008) Mapping and quantifying mammalian transcriptomes by RNA-Seq. Nat Methods 5: 621–628.
62. SchneiderTD, StephensRM (1990) Sequence logos: a new way to display consensus sequences. Nucleic Acids Res 18: 6097–6100.
63. CrooksGE, HonG, ChandoniaJM, BrennerSE (2004) WebLogo: a sequence logo generator. Genome Res 14: 1188–1190.
64. MajerciakV, YamanegiK, NieSH, ZhengZM (2006) Structural and functional analyses of Kaposi sarcoma-associated herpesvirus ORF57 nuclear localization signals in living cells. J Biol Chem 281: 28365–28378.
65. PilkingtonGR, MajerciakV, BearJ, UranishiH, ZhengZM, et al. (2012) Kaposi's sarcoma-associated herpesvirus ORF57 is not a bona fide export factor. J Virol 86: 13089–13094.
66. MassimelliMJ, KangJG, MajerciakV, LeSY, LiewehrDJ, et al. (2011) Stability of a Long Noncoding Viral RNA Depends on a 9-nt Core Element at the RNA 5′ End to Interact with Viral ORF57 and Cellular PABPC1. Int J Biol Sci 7: 1145–1160.
67. LivakKJ, SchmittgenTD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402–408.